CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+4.3%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$4.96B
AUM Growth
+$4.96B
(+3.8%)
Cap. Flow
+$95.1M
Cap. Flow
% of AUM
1.92%
Top 10 Holdings %
Top 10 Hldgs %
16.47%
Holding
684
New
65
Increased
264
Reduced
253
Closed
50
Top Buys
| 1 |
Amgen
AMGN
|
$53.9M |
| 2 |
Visa
V
|
$45.7M |
| 3 |
Johnson & Johnson
JNJ
|
$42.3M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$28.2M |
| 5 |
PepsiCo
PEP
|
$27.2M |
Top Sells
| 1 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
$29.3M |
| 2 |
ADT
ADT CORP
ADT
|
$26.4M |
| 3 |
First Solar
FSLR
|
$24.8M |
| 4 |
Cigna
CI
|
$23.7M |
| 5 |
AET
Aetna Inc
AET
|
$21.7M |
Sector Composition
| 1 | Healthcare | 27.7% |
| 2 | Financials | 13.24% |
| 3 | Technology | 10.61% |
| 4 | Industrials | 7.93% |
| 5 | Consumer Discretionary | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amgen
AMGN
$155B
| $127M | 2.56% | 794,961 +336,833 | +74% | +$53.9M |
|
|
2
Johnson & Johnson
JNJ
$427B
| $96.9M | 1.95% | 962,812 +420,546 | +78% | +$42.3M |
|
3
Gilead Sciences
GILD
$140B
| $93.5M | 1.88% | 952,890 +64,765 | +7% | +$6.36M |
|
4
Apple
AAPL
$3.45T
| $92.9M | 1.87% | 746,741 +27,998 | +4% | +$3.48M |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $82M | 1.65% | 711,378 -44,170 | -6% | -$5.09M |
|
6
Biogen
BIIB
$19.4B
| $79.9M | 1.61% | 189,283 +1,255 | +0.7% | +$530K |
|
|
7
Alphabet (Google) Class C
GOOG
$2.58T
| $78.4M | 1.58% | 142,404 +51,279 | +56% | +$28.2M |
|
|
8
Visa
V
$683B
| $58M | 1.17% | 886,753 +697,990 | +370% | +$45.7M |
|
9
Qualcomm
QCOM
$173B
| $54.6M | 1.1% | 787,825 -216,965 | -22% | -$15M |
|
10
Regeneron Pharmaceuticals
REGN
$61.5B
| $53.9M | 1.08% | 119,253 +39,112 | +49% | +$17.7M |
|
11
Exxon Mobil
XOM
$487B
| $53.3M | 1.07% | 627,188 -75,999 | -11% | -$6.46M |
|
12
Intuit
INTU
$186B
| $52.3M | 1.05% | 539,754 -12,297 | -2% | -$1.19M |
|
13
Merck
MRK
$210B
| $49.5M | 1% | 861,330 +32,648 | +4% | +$1.88M |
|
14
Bristol-Myers Squibb
BMY
$96B
| $46.3M | 0.93% | 717,733 +333,506 | +87% | +$21.5M |
|
15
Meta Platforms (Facebook)
META
$1.86T
| $44.5M | 0.9% | 541,545 +77,905 | +17% | +$6.41M |
|
16
Verizon
VZ
$186B
| $41.3M | 0.83% | 849,494 -29,215 | -3% | -$1.42M |
|
|
17
PepsiCo
PEP
$204B
| $41.1M | 0.83% | 429,307 +283,886 | +195% | +$27.2M |
|
18
iShares MSCI Japan ETF
EWJ
$15.3B
| $40.8M | 0.82% | 3,255,538 +40,404 | +1% | +$506K |
|
19
Mastercard
MA
$538B
| $40.8M | 0.82% | 472,028 +283,056 | +150% | +$24.5M |
|
20
Nike
NKE
$114B
| $40.6M | 0.82% | 404,994 +146,323 | +57% | +$14.7M |
|
21
Pfizer
PFE
$141B
| $39.1M | 0.79% | 1,124,217 -514,265 | -31% | -$17.9M |
|
22
Rockwell Automation
ROK
$38.6B
| $38.5M | 0.78% | 331,649 +154,240 | +87% | +$17.9M |
|
23
AT&T
T
$209B
| $37.4M | 0.75% | 1,146,722 +55,471 | +5% | +$1.81M |
|
24
Colgate-Palmolive
CL
$67.9B
| $36.3M | 0.73% | 522,741 +981 | +0.2% | +$68K |
|
25
Coca-Cola
KO
$297B
| $36M | 0.73% | 888,671 -55,103 | -6% | -$2.23M |
|